Markets
Pharmaceutical company, Cerevance, has secured additional funding to develop its novel therapeutics for central nervous system (CNS) diseases, including Parkinson’s. The drug development company has announced an expansion of its Series B funding round with an additional close of $51 million, bringing the total Series B financing to $116 million. The financing will support upcoming [...]
The fourth annual iN2L + LifeLoop survey of senior living leaders explores the evolving role of technology within community life. The need for innovative technology to augment highly personalised care is growing in the senior living industry as it continues its post-pandemic recovery. This is one finding of a comprehensive, independently conducted survey of industry [...]
Newel Health has been awarded $2.5M from The Michael J Fox Foundation for the development of its innovative digital therapeutic solution for people with Parkinson’s disease. The research grant is to further advance the research and development of Newel Health’s Soturi, a Digital Therapeutic (DTx) solution for personalised medication and treatment plan optimisation for people [...]
The collaboration focuses on offering affordable hearing aids which can be purchased through health insurance.
Global investment in the longevity sector is demonstrating stronger resilience than the biotech and fintech sectors, according to a new report. Industry analysts at Longevity.Technology have published the 2022 Annual Longevity Investment Report on the state of investment in the longevity sector. The report analyses the companies and investors behind technologies designed to extend the number [...]
The acquisition expands CareAcademy’s ability to serve a broader healthcare ecosystem in home and community settings.
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. - a US-based clinical-stage biopharmaceutical company that develops novel treatments for hypertension and chronic kidney disease. The acquisition will grow AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107). The drug is an aldosterone synthase inhibitor (ASI) for blood pressure lowering in [...]
The successful businesses will be supported by UK and Canadian experts.
Nymbl Science has been recognised for its work to improve quality of life for older adults.
The funding will enable the company to scale up its home care network across the UK.
